VigiPallia : Résultats

COUT SANTE

0 sélectionnée(s) / 61 réponse(s)

(1) 2 3 4 > »

Chimeric antigen receptor T cell immunotherapy - what you need to know #393

SEDHOM, Ramy ; GUPTA, Arjun ; EL-JAWAHRI, Areej R.
JOURNAL OF PALLIATIVE MEDICINE, 06/2020, vol.23, n°6, p. 863-864

Association of billed advance care planning with end-of-life care intensity for 2017 medicare decedents

GUPTA, Avni ; JIN, Ginger ; REICH, Amanda ; PRIGERSON, Holly G. ; LADIN, Keren ; KIM, Dae ; ASHANA, Deepshikha Charan ; COOPER, Zara ; HALPERN, Scott D. ; WEISSMAN, Joel S.
Journal of the American Geriatrics Society, 27/08/2020, Pagination inconnue

Document en ligne

Exploring the cost-effectiveness of advance care planning (by taking a family carer perspective) - findings of an economic modelling study

BAUER, Annette ; DIXON, Josie ; KNAPP, Martin ; WITTENBERG, Raphael
Health and social care in the community, 11/08/2020, Pagination inconnue

Document en ligne

Exploring the costs, consequences and efficiency of three types of palliative care day services in the UK - a pragmatic before-and-after descriptive cohort study

MITCHELL, Paul Mark ; COAST, Joanna ; MYRING, Gareth ; RICCIARDI, Federico ; VICKERSTAFF, Victoria ; JONES, Louise ; ZAFAR, Shazia ; CUDMORE, Sarah ; JORDAN, Joanne ; MCKIBBEN, Laurie ; GRAHAM-WISENER, Lisa ; FINUCANE, Anne M. ; HEWISON, Alistair ; HARALDSDOTTIR, Erna ; BRAZIL, Kevin ; KERNOHAN, W. George
BMC palliative care, 07/08/2020, vol.19, n°1, p. 1-9

Document en ligne

Regional differences in healthcare costs at the end of life - an observational study using Swiss insurance claims data

BAHLER, Caroline ; RAPOLD, Roland ; SIGNORELL, Andri ; REICH, Oliver ; PANCZAK, Radoslaw ; BLOZIK, Eva
International journal of public health, 15/07/2020, Pagination inconnue

Document en ligne

Factors associated with aggressiveness of end-of-life care for lung cancer patients and associated costs of care

BYLICKI, Olivier ; RIVIÈRE, Fréderic ; TOURNIER, Charlène ; CANOUI-POITRINE, Florence ; GRASSIN, Fréderic ; MARGERY, Jacques ; PRODEL, Martin ; VAINCHTOCK, Alexandre ; ASSIE, Jean-Baptiste ; CHOUAÏD, Christos
Clinical lung cancer, 23/05/2020, Pagination inconnue

Document en ligne

Health economic and health service issues of palliative radiotherapy

BARTON, M. ; BATUMALAI, V. ; SPENCER, K.
Clinical oncology, 06/07/2020, Pagination inconnue

Document en ligne

A systematic intervention to improve serious illness communication in primary care - effect on expenses at the end of life

LAKIN, Joshua R. ; NEAL, Brandon J. ; MALONEY, Francine L. ; PALADINO, Joanna ; VOGELI, Christine ; TUMBLIN, Joey ; VIENNEAU, Maryann ; FROMME, Erik ; CUNNINGHAM, Rebecca ; BLOCK, Susan D. ; BERNACKI, Rachelle E.
Healthcare, 06/2020, vol.8, n°2, Pagination inconnue

Document en ligne

Associations between end-of-life expenditures and hospice stay length vary by clinical condition and expenditure duration

HUNG, Peiyin ; HSU, Sylvia H. ; WANG, Shi-Yi
VALUE IN HEALTH, 06/2020, vol.23, n°6, p. 697-704

Document en ligne

Cost-effectiveness of investment in end-of-life home care to enable death in community settings

ISENBERG, Sarina R. ; TANUSEPUTRO, Peter ; SPRUIN, Sarah ; SEOW, Hsien ; GOLDMAN, Russell ; THAVORN, Kednapa ; HSU, Amy T.
Medical Care, 05/06/2020, Pagination inconnue

Document en ligne

Complementary music therapy for cancer patients in at-home palliative care and their caregivers - protocol for a multicentre randomised controlled trial

VALERO-CANTERO, Inmaculada ; MARTINEZ-VALERO, Francisco Javier ; ESPINAR-TOLEDO, Milagrosa ; CASALS, Cristina ; BARON-LOPEZ, Francisco Javier ; VAZQUEZ-SANCHEZ, Maria Angeles
BMC palliative care, 02/05/2020, vol.19, n°1, p. 1-11

Document en ligne

Goals-of-care consultations are associated with lower costs and less acute care use among propensity-matched cohorts of African Americans and whites with serious illness

STARR, Lauren T. ; ULRICH, Connie M. ; APPEL, Scott M. ; JUNKER, Paul ; O'CONNOR, Nina R. ; MEGHANI, Salimah H.
JOURNAL OF PALLIATIVE MEDICINE, 27/04/2020, Pagination inconnue

Document en ligne

Economic evaluation of a combined screening and stepped-care treatment program targeting psychological distress in patients with metastatic colorectal cancer - a cluster randomized controlled trial

EL ALILI, Mohamed ; SCHUURHUIZEN, Claudia S. E. W. ; BRAAMSE, Annemarie M. J. ; BEEKMAN, Aartjan T. F. ; VAN DER LINDEN, Mecheline H. ; KONINGS, Inge R. ; DEKKER, Joost ; BOSMANS, Judith E.
PALLIATIVE MEDICINE, 07/2020, vol.34, n°7, p. 934-945

Document en ligne

Impact of socioeconomic status on end-of-life costs - a systematic review and meta-analysis

YU, Caberry W. ; ALAVINIA, S. Mohammad ; ALTER, David A.
BMC palliative care, 12/2020, vol.19, n°1, p. 1-15

Document en ligne

Thème : Santé. Cote : eD01.01.02

FIN VIE ; COUT SANTE ; REVUE SYSTEMATIQUE ; META-ANALYSE

Background: Socioeconomic inequalities in access to, and utilization of medical care have been shown in many jurisdictions. However, the extent to which they exist at end-of-life (EOL) remains unclear.
Methods: Studies in MEDLINE, EMBASE, CINAHL, ProQuest, Web of Science, Web of Knowledge, and OpenGrey databases were searched through December 2019 with hand-searching of in-text citations. No publication date or language limitations were set. Studies assessing SES (e.g. income) in adults, correlated to EOL costs in last year(s) or month(s) of life were selected. Two independent reviewers performed data abstraction and quality assessment, with inconsistencies resolved by consensus.
Results: A total of twenty articles met eligibility criteria. Two meta-analyses were performed on studies that examined total costs in last year of life – the first examined costs without adjustments for confounders (n = 4), the second examined costs that adjusted for confounders, including comorbidities (n = 2). Among studies which did not adjust for comorbidities, SES was positively correlated with EOL costs (standardized mean difference, 0.13 [95% confidence interval, 0.03 to 0.24]). However, among studies adjusting for comorbidities, SES was inversely correlated with EOL expenditures (regression coefficient, -$150.94 [95% confidence interval, -$177.69 to -$124.19], 2015 United States Dollars (USD)). Higher ambulatory care and drug expenditure were consistently found among higher SES patients irrespective of whether or not comorbidity adjustment was employed.
Conclusion: Overall, an inequality leading to higher end-of-life expenditure for higher SES patients existed to varying extents, even within countries providing universal health care, with greatest differences seen for outpatient and prescription drug costs. The magnitude and directionality of the relationship in part depended on whether comorbidity risk-adjustment methodology was employed.

Origine : DOI.org (Crossref

Palliative care in ruptured aortic aneurysm in the United States - a retrospective analysis of nationwide inpatient sample database

ANDO, Tomo ; ADEGBALA, Oluwole ; UEMURA, Takeshi ; ASHRAF, Said ; AKINTOYE, Emmanuel ; PAHUJA, Mohit ; AFONSO, Luis ; BRIASOULIS, Alexandros ; TAKAGI, Hisato
Angiology, 06/04/2020, Pagination inconnue

Document en ligne

Variability of cost trajectories over the last year of life in patients with advanced breast cancer in the Netherlands

SCHNEIDER, Paul P. ; POUWELS, Xavier G. L. V. ; PASSOS, Valéria Lima ; RAMAEKERS, Bram L. T. ; GEURTS, Sandra M. E. ; IBRAGIMOVA, Khava I. E. ; DE BOER, Maaike ; ERDKAMP, Frans ; VRIENS, Birgit E. P. J. ; VAN DE WOUW, Agnes J. ; DEN BOER, Marien O. ; PEPELS, Manon J. ; TJAN-HEIJNEN, Vivianne C. G. ; JOORE, Manuela A.
Plos one, 09/04/2020, vol.15, n°4, p. 1-14

Document en ligne

Association of declines in end-of-life health care costs with fee-for-service enrollee per capita expenditures

WEEKS, William B. ; CAO, Stacey Y. ; LESTER, Chris M. ; WEINSTEIN, James N.
JAMA network open, 02/03/2020, vol.3, n°3, p. 1-5

Document en ligne

Assessing the impact of early identification of patients appropriate for palliative care on resource use and costs in the final month of life

LOOK HONG, Nicole J. ; LIU, Ning ; WRIGHT, Frances C. ; MACKINNON, Marnie ; SEUNG, Soo Jin ; EARLE, Craig C. ; GRADIN, Sharon ; SATI, Saurabh ; BUCHMAN, Sandy ; MITTMANN, Nicole
JCO oncology practice, 20/03/2020, Pagination inconnue

Document en ligne

Health care costs at end-of-life for patients with idiopathic pulmonary fibrosis - evaluation of a pilot multidisciplinary clinic

KALLURI, Meena ; LU-SONG, Jenny ; YOUNUS, Sarah ; NABIPOOR, Majid ; RICHMAN-EISENSTAT, Janice ; OHINMAA, Arto ; BAKAL, Jeffrey A.
Annals of the American Thoracic Society, 20/03/2020, Pagination inconnue

Document en ligne

Thème : Médecine.

COUT SANTE ; FIN VIE ; MALADIE RESPIRATOIRE ; DEMARCHE PALLIATIVE ; TRAJECTOIRE MALADIE

RATIONALE: Even though Idiopathic pulmonary fibrosis (IPF) is a disease with high morbidity and mortality and no cure, palliative care is rarely implemented, leading to high symptom burden and unmet care needs. In 2012 we implemented a Multidisciplinary Collaborative (MDC) care model linking clinic and community multidisciplinary teams to provide an early-integrated palliative approach, focusing on early symptom management and advanced care planning (ACP).
OBJECTIVES: This study evaluates the differences in resource utilization and associated costs of end-of-life care between early-integrated palliative and conventionally treated IPF patients.
METHODS: Using administrative health data, we identified all patients in Alberta who presented to hospital with an IPF diagnosis between Jan 1, 2012 and Dec 31, 2018 and died within this timeframe. We compared 3 groups of patients: those who received (1) MDC care (our clinic patients), (2) specialist care (SC; respirologist), and (3) non-specialist care (NSC; no contact with a respiratory clinic). The primary outcomes were health care resource utilization and costs in the year before death.
RESULTS: Of 2,768 patients across three groups, MDC patients were over 3 times more likely to have received anti-fibrotic therapies over SC patients (OR=3.0; 95%CI 1.8-5.2), almost twice as likely to receive pulmonary rehab (OR=1.9; 95%CI 1.1-3.4) and 36% more likely to receive opiates (OR=1.4; 95%CI 0.8-2.3) in the last year of life. The median total health care costs in the last 3 months of life were approximately $7,700 CDN lower for MDC patients compared to those receiving specialist care, driven primarily by fewer hospitalizations and ED visits. MDC patients were also less likely to die in hospital (44.9% MDC vs 64.9% SC vs 66.8% NSC, p<0.001) and had the highest rates of no hospitalization in the last year of life.
CONCLUSIONS: An integrated palliative approach in IPF is associated with improvements in the quality of end-of-life care and reduction in costs. Transformation of care models is required to deliver a palliative approach in IPF. Multidisciplinary collaborative teams within such models can address the high burden of unmet needs for symptom management, advance care planning (ACP) and community support in this complex population.

Origine : PubMed

(1) 2 3 4 > »

Actions

##titre_notice##